Merit Medical Systems (NASDAQ: MMSI) is a medical device company that manufactures and sells disposable medical products used in diagnostic and interventional procedures. Revenue is generated through transactional sales of single-use devices to hospitals, clinics, and other healthcare facilities. The company trades on the NASDAQ Global Select Market and has expanded its product portfolio through acquisitions, including businesses and products acquired from Cook Medical Holdings LLC and EndoGastric Solutions, Inc. in 2024, and from Pentax of America, Inc. and Biolife, L.L.C. in 2025, per the FY2025 10-K filed 2026-02-24. Operations are subject to U.S. and global regulatory, reimbursement, and competitive conditions, with supply chain and sterilization processes cited as material operational risks.
- Revenue model
- Transactional sales of disposable, single-use medical devices to hospitals and healthcare facilities. The filing excerpts do not provide segment revenue breakdowns or percentage splits.
- Products and services
- Disposable medical products used in diagnostic and interventional procedures. Recent additions include products acquired from Cook Medical Holdings LLC, EndoGastric Solutions Inc. (2024), Pentax of America Inc., and Biolife L.L.C. (2025). Specific product names are not detailed in the available filing excerpts.
- Customers and end markets
- Hospitals, clinics, and healthcare facilities performing diagnostic and interventional procedures. Specific customer concentration data and end-market percentages are not supported by the available filing excerpts.
- Value-chain role
- Medical device manufacturer and seller of disposable, single-use procedural products. Manages its own manufacturing and sterilization processes, which are cited as operational risk factors in the FY2025 10-K.
- Geographic exposure
- U.S. and international markets. The filing references U.S. and global political, economic, and regulatory conditions, as well as trade policy and tariff risks, indicating meaningful international exposure. Specific revenue percentages by geography are not supported by the available excerpts.
Source: SEC 10-K, filed 2026-02-24
Industry:
Surgical & Medical Instruments & Apparatus
Peers:
Embecta Corp
QuidelOrtho Corp
Figs Inc
Haemonetics Corp
ICU Medical Inc
MERIDIAN BIOSCIENCE INC
Neogen Corp
Silk Road Medical Inc
STAAR Surgical Co